Personalized Assessment of Client Experiences

Overview

The purpose of this study is to compare two clinical approaches to youth mental health care.

Full Title of Study: “Improving Measurement-Based Care in Youth Mental Health: A Comparison of Unidimensional and Multidimensional Approaches”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Single (Participant)
  • Study Primary Completion Date: January 2022

Interventions

  • Behavioral: Measurement-Based Care
    • Both study conditions will receive measurement-based care, which is the systematic, ongoing administration of assessment measures to support clinical decision-making.

Arms, Groups and Cohorts

  • Experimental: Unidimensional Measurement-Based Care
    • Youth and caregivers will complete a symptom rating scale every session. Clinicians will receive feedback reports summarizing these data, including alerts indicating if the youth is on track for positive treatment outcomes. These feedback reports will be used to support clinical decision-making.
  • Experimental: Multidimensional Measurement-Based Care
    • Youth and caregivers will complete battery of questionnaires covering multiple process and outcome domains every session. Clinicians will receive feedback reports summarizing these data, including alerts indicating if the youth is on track for positive treatment outcomes. These feedback reports will be used to support clinical decision-making.

Clinical Trial Outcome Measures

Primary Measures

  • Change in The Ohio Scales Problem Severity Scale Youth Report
    • Time Frame: baseline, 12 weeks
    • A youth-report measure of youth symptoms ranging from 0 to 100, with higher scores indicating higher general mental health symptoms.
  • Change in The Ohio Scales Problem Severity Scale Caregiver Report
    • Time Frame: baseline, 12 weeks
    • A caregiver-report measure of youth symptoms ranging from 0 to 100, with higher scores indicating higher general mental health symptoms.
  • Change in The Ohio Scales Problem Functioning Scale Youth Report
    • Time Frame: baseline, 12 weeks
    • A youth-report measure of youth functioning in a variety of areas of daily living ranging from 0 to 80, with higher scores indicating better functioning.
  • Change in The Ohio Scales Problem Functioning Scale Caregiver Report
    • Time Frame: baseline, 12 weeks
    • A caregiver-report measure of youth functioning in a variety of areas of daily living ranging from 0 to 80, with higher scores indicating better functioning.
  • Change in Symptoms & Functioning Severity Scale- Youth Report
    • Time Frame: baseline, up to 18 months
    • A youth-report measure of youth mental health symptoms. Scores are reported as a total score, ranging from 33 to 86, with higher scores indicating higher symptoms.
  • Change in Symptoms & Functioning Severity Scale- Caregiver Report
    • Time Frame: baseline, up to 18 months
    • A caregiver-report measure of youth mental health symptoms. Scores are reported as a total score, ranging from 30 to 82, with higher scores indicating higher symptoms.

Participating in This Clinical Trial

Inclusion Criteria

1. Male or female youth between the ages of 11-17 years receiving mental health services at the participating clinics.

2. The treating clinician is participating in the study and determines that Measurement-Based Care (MBC) is appropriate for the youth.

3. If the family consents to complete additional research measures, one parent and/or primary caregiver must be available and willing to participate in all study assessments.

4. Adolescent and at least one parent/guardian are able to complete all study procedures in English or Spanish.

Exclusion Criteria

  • no other exclusion criteria

Gender Eligibility: All

Minimum Age: 11 Years

Maximum Age: 17 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University of Miami
  • Collaborator
    • Vanderbilt University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Amanda Jensen-Doss, Associate Professor – University of Miami
  • Overall Official(s)
    • Susan Douglas, Ph.D., Principal Investigator, Vanderbilt University
    • Amanda Jensen-Doss, Ph.D., Principal Investigator, University of Miami
  • Overall Contact(s)
    • Amanda Jensen-Doss, Ph.D., 305-284-8332, ajensendoss@miami.edu

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.